key: cord-0827116-jr7mrnb5 authors: Afrazi, Amin; Garcia-Rodriguez, Sylvana; Maloney, James D; Morgan, Clinton T title: Cavitary lung lesions and pneumothorax in a healthy patient with active coronavirus-19 (COVID-19) viral pneumonia date: 2020-12-23 journal: Interact Cardiovasc Thorac Surg DOI: 10.1093/icvts/ivaa238 sha: fd8889cc8c05060c685264ee1f77743cbb90f4a2 doc_id: 827116 cord_uid: jr7mrnb5 Severe respiratory sequelae drive morbidity-associated with coronavirus 2019 (COVID-19) disease. We report a case of COVID-19 pneumonia complicated by cavitary lesions and pneumothorax in a young healthy male. Pneumothorax management with catheter thoracostomy and rapid resolution of the cavitary lesions are described. An extensive work-up for other causes a cavitation was negative and the temporal correlation of the cavities with COVID-19 infection plus their rapid resolution suggest a direct relationship. We propose a mechanism for cavitation secondary to microangiopathy, a cause of cavitation in the vasculitides and a known feature of COVID-19. A 35-year-old male presented to our Emergency Department on 21 April with chest pain and scant haemoptysis. On April 8, he had a positive coronavirus 2019 (COVID-19) nasopharyngeal swab and reverse-transcription polymerase chain reaction of the ORF1ab gene using the Panther Aptima V R SARS-CoV-2 assay (Hologic, Marlborough, MA, USA). His initial symptoms of fever, cough and fatigue resolved after several days at home without medications. He was previously healthy and denied family history of pulmonary disease. He endorsed rare alcohol consumption but denied tobacco or illicit drug use. He denied exposures to moulds, tuberculosis or atypical bacterial infections. He was afebrile, with a benign examination. Laboratories were unremarkable (Supplementary Material, Table S1) Table S2 ). While the pneumothorax confounds comparison of the initial RLL cavity size to the cavity size in the reexpanded lung (Supplementary Material, Table S2 ), a slight increase was noted. The RUL lesion was more complex but decreased in size (Supplementary Material, Fig. S3a and b and Supplementary Material, Table S2 ). The LLL cavity clearly decreased (Fig. 1b and d and Supplementary Material, Table S2 ). After a negative infectious work-up, the patient discharged on 27 April 2020 (Table 1) . He underwent CT on 27 May 2020 for mild dyspnoea but required no interventions. The CT revealed a markedly decreased RLL cavity and LLL cavity resolution ( Table S2 ). In addition, he underwent pulmonary function testing on 16 June 2020, which was unremarkable ( Supplementary Material, Fig. S5 ). He is currently doing well and has scheduled follow-up. Cavitary lung disease caused by COVID-19 viral pneumonia has not been described [1, 2] . Cavitary lung disease has many causes, including infectious, neoplastic, vasculitides and congenital. Our rigorous work-up excluded many aetiologies for cavitary disease. There was no evidence for neoplasm and rapid changes are not consistent with congenital aetiologies. No chest imaging exists prior to his presentation in April, making it difficult to exclude preexisting subclinical pulmonary disease with absolute certainty. The extensive negative work-up, temporal correlation between the cavities and COVID-19 infection and rapid cavity resolution suggest a direct link between cavitation and COVID-19 infection. Our patient had positive repeat COVID-19 nasopharyngeal swab/reversetranscription polymerase chain reaction tests 17 and 26 days after his initial positive test. Zheng et al. [3] recently reported that more severe pulmonary complications were associated with higher viral loads and a longer duration of COVID-19 infection. Could our patient's positive repeat COVID-19 tests represent prolonged infection causing pulmonary complications? If COVID-19 infection directly caused the cavities, what is the mechanism? Ackermann et al. [4] reported microvascular pulmonary endothelialitis in COVID-19 autopsies. Small-vessel vasculitis represents a known aetiology for cavitation [5] . It is tempting to speculate that the microangiopathy known to occur in COVID-19 infection could represent a plausible mechanism for cavitary lesions in our patient. Supplementary material is available at ICVTSonline. Interactive CardioVascular and Thoracic Surgery thanks Clemens Aigner and René Horsleben Petersen for their contribution to the peer review process of this article. Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist Radiology perspective of coronavirus disease 2019 (COVID-19): lessons from severe acute respiratory syndrome and middle east respiratory syndrome Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19 Pulmonary vasculitis We thank Alejandro Roldan-Alzate for image analysis suggestions.